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Introduction
Cell cycle genes and specifi cally those genes that regulate the 
G1/S transition have been shown to play an important role in 
regulating the neural precursor population. Members of the 
 cyclin-dependent kinase inhibitor (CDKI) family have received 
much of the attention. CDKIs, p21Cip1, and p27Kip1 negatively 
regulate embryonic and adult neural precursor proliferation 
(Doetsch et al., 2002; Kippin et al., 2005). Bmi-1 promotes self-
renewing cell division in both hematopoeitic and neural precur-
sors through the transcriptional repression of CDKIs, p16Ink4a, 
and p19Arf (Molofsky et al., 2003, 2005). However, cell cycle 
regulators impacting the neural precursor population are not 
only restricted to CDKIs (McClellan and Slack, 2006). We have 
recently shown that the Retinoblastoma (Rb) family member 
p107, an inhibitor of the cell cycle G1/S transition, negatively 
regulates the neural precursor pool in the developing and 
adult brain by regulating self-renewal (Vanderluit et al., 2004). 
p107 has been shown to function by interacting with E2F tran-
scription factors (preferentially E2F4) to repress the transcrip-
tion of genes required for cell cycle progression (Stevaux and 
Dyson, 2002). Distinct from other Rb family members, p107 is 
only expressed in cycling neural precursor cells in the ventricular 
zone (VZ; Jiang et al., 1997).
The Notch–Hes pathway is necessary for self-renewing 
cell division and, thus, maintenance of the neural precursor pop-
ulation (Ishibashi et al., 1995; Ohtsuka et al., 2001; Hitoshi et al., 
2002; Hatakeyama et al., 2004). Whereas the deletion of either 
Notch1, Hes1, or Hes1 and Hes5 causes premature differentia-
tion of embryonic neural precursors, resulting in their depletion 
(Ishibashi et al., 1995; Ohtsuka et al., 2001; Hitoshi et al., 2002), 
the overexpression of activated Notch1 or Hes1 results in an 
expansion of neural precursor numbers (Ishibashi et al., 1994). 
Hes1 and Hes5 inhibit differentiation by repressing the expres-
sion of the proneural genes Mash1, NeuroD, and Math1 (Sasai 
et al., 1992; Ishibashi et al., 1995). Because the Notch–Hes 
 signaling pathway is crucial for neural precursor self-renewal and 
inhibition of premature differentiation, we asked whether the cell 
cycle protein p107 may be regulating the neural precursor popu-
lation and progenitor differentiation by the repression of Hes1.
In this study, we demonstrate that the p107-mediated regu-
lation of neural precursor number occurs through the repression 
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Figure 1. Increased numbers of progenitor cells in the embryonic and 
adult p107−/− brains in vivo. (a–c) To assess the size of the neural progenitor 
population in the adult brain, mice received intraperitoneal injections of 
BrdU to label proliferating cells over a 10-h period. BrdU-positive cell 
counts through the lateral ventricles showed a 50% increase in the number 
of progenitors in p107−/− brains (n = 4) in comparison with wild type (n = 3). 
(d) The adult progenitor population was also assessed by immunohisto-
chemistry for PCNA. Similar to our BrdU incorporation study, p107-defi cient 
brains had a comparable increase in PCNA+ cells along the ventricles. 
(e) To quantify the number of proliferating progenitors in E10.5 brains, 
we used an antibody to phosphohistone H3 (PH3), a marker of cells in 
M phase of the cell cycle. PH3-positive cells were counted along the lateral 
ventricles in three representative sections of wild-type (n = 3) and p107−/− 
(n = 3) brains. (f) A 2-h BrdU pulse was used to label progenitors in S 
phase in E13.5 brains. BrdU-positive cells were counted in four representative 
regions of the forebrain in wild-type (n = 4) and p107−/− (n = 3) embryos. 
Note that at adult and embryonic ages, p107−/− mice had signifi cantly 
more proliferating cells along the lateral ventricle than wild-type mice. 
(g and h) To assess whether in vivo cell cycle kinetics were different in p107−/− 
neural progenitors, we compared the size of the S-phase fraction by immuno-
labeling for BrdU and PCNA in adult (g) and E13.5 wild-type and p107−/− 
cortices (h). Quantifi cation of BrdU+ cells (S-phase fraction) was compared 
with the total proliferating population (PCNA+). After 10.5 h of cumulative 
BrdU  labeling, 78.2% and 78% of the total proliferating populations in 
wild-type and p107−/− cortices were BrdU+, respectively, indicating similar 
cell cycle kinetics. At E13.5 after a 2-h BrdU pulse, 53.6% and 51.2% of 
the total proliferating populations in wild-type and p107−/− were BrdU+, 
 respectively. Means were statistically analyzed using a t test, and differ-
ences were assessed at *, P < 0.05. Error bars represent SEM. Bar, 100 μm.
of Hes1 transcription. Hes1 is elevated in p107-defi cient brains. 
Loss of a single Hes1 allele restores the neural precursor 
population to wild-type levels both in vitro and in vivo. Despite 
the expanded progenitor population, p107- defi cient brains ex-
hibit a reduction in the number of cortical neurons that cannot be 
accounted for by apoptosis. Short- and long-term BrdU labeling 
studies revealed a striking defect in the rate at which p107-null 
progenitors commit to a neuronal fate. Loss of a single Hes1 al-
lele on a p107-null background rescues the number of neurons 
born during cortical development. Together, these results identify 
that the mechanism by which p107 regulates both neural pre-
cursor self-renewal and differentiation is through regulation of 
the Notch–Hes1 signaling pathway. In summary, we identify a 
novel function for p107, a cell cycle regulatory protein, in con-
trolling the onset of differentiation.
Results
p107 regulates the size of the neural 
precursor population
To determine the temporal requirement for p107 in regulating 
the neural precursor population, we counted the number of pro-
liferating precursors in the brains of mice at three different ages: 
in adults and in embryos at embryonic days (E) 10.5 and 13.5. 
Using antibodies to label cells in the cell cycle (proliferating 
cell nuclear antigen [PCNA], which labels cells in all phases of 
the cell cycle; phosphohistone H3 [PH3], which labels cells in 
M phase; and BrdU, which gets incorporated during S phase), 
we demonstrate an increase in the proliferating precursor popu-
lation in p107-null mice. Adult p107-null mice have a 50% 
 increase in the number of precursors, as demonstrated by both 
cumulative BrdU labeling of proliferating progenitor cells and 
PCNA immunostaining (Fig. 1, a–d). Similarly, at both embry-
onic time points E10.5 and 13.5, p107-null embryos had more 
precursor cells (Fig. 1, e and f). The difference is most pro-
nounced in adult mice when proliferation rates are slower, with 
a cell cycle time of 12.7 h (Morshead and van der Kooy, 
1992). These studies demonstrate that p107 mutants have an 
 expanded precursor population.
As the increased number of neural precursor cells in 
p107-defi cient mice could be the result of an increased total 
population or an enhanced rate of cell division, we assessed 
the prolif erative index in embryonic and adult wild-type and 
p107−/− mice. Double immunohistochemistry for BrdU and 
PCNA was performed on adult brains after 10.5 h of cumula-
tive BrdU labeling and on embryonic brains after a 2-h pulse of 
BrdU. The number of cells that entered S phase (BrdU+ cells) 
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Figure 2. Hes1 expression is deregulated in p107−/− precursor cells. 
(a and b) In situ hybridization revealed higher levels of Hes1 mRNA in the 
VZ of E14.5 p107−/− mice versus wild-type littermates. (c) Elevated levels 
of Hes1 mRNA were also demonstrated by real-time RT-PCR on whole corti-
ces from E12.5 wild-type (n = 4) and p107−/− (n = 4) embryos. (d–f) In 
contrast, no difference was observed in the levels of Hes5 mRNA between 
wild type and p107−/− by in situ hybridization (d and e) or real-time 
RT-PCR (f). (g) Neuroepithelia from E10.5 wild-type (wt) and p107−/− mice 
were cultured as neurospheres. Protein was isolated from the neurospheres 
for Western blot analysis. A representative Western blot initially probed 
with an antibody to Hes1 and then reprobed with an antibody to actin to 
verify equal quantities of protein was loaded per lane. The experiment was 
performed in triplicate. Vz, ventricular zone; C, cortical plate and IZ. 
Means were analyzed by a t test with *, P < 0.05. Error bars represent 
SEM. Bar, 50 μm.
was compared with the total proliferating population (PCNA-
expressing cells) in wild-type and p107−/− mice. A more rapid 
cell cycle time in p107 knockouts would result in a greater 
percentage of cells in S phase (Cayre et al., 2005). In adult 
wild-type mice, 78.2 ± 1.4% of the proliferating population 
incorporated BrdU, whereas in p107−/− mice, 78.0 ± 1.9% 
were BrdU positive (Fig. 1 g). After a 2-h BrdU pulse at E13.5, 
53.6 ± 1.8% of wild-type and 51.3 ± 3.2% of p107−/− cells 
incorporated BrdU (Fig. 1 h). Thus, comparable proliferative 
indices in adult and embryonic ages indicate similar cell cycle 
times. Therefore, the increased number of total progenitor cells 
at each stage of development represents an overall expansion 
of the precursor population in p107−/− mice. This increase in 
total precursor number is consistent with our previous studies 
revealing that p107-defi cient animals exhibit elevated levels 
of the Notch1–Hes1 pathway and increased stem cell self-
 renewal (Vanderluit et al., 2004). As the Notch1 pathway has 
been shown to play an essential role in stem cell self-renewal 
(Hitoshi et al., 2002), our expanded precursor population in 
p107 defi ciency is consistent with an increase in the Notch–
Hes1 pathway. Therefore, we asked whether the expanded pre-
cursor population in p107-defi cient mice is the result of the 
deregulation of Hes1.
Deregulated Hes1 expression in p107−/− 
neural precursors
Because we have previously demonstrated the deregulation of 
Notch signaling in p107-defi cient neural precursors  (Vanderluit 
et al., 2004), we examined the expression of Notch targets 
Hes1 and Hes5 in p107 defi ciency. Hes1 and Hes5 are basic 
helix-loop-helix transcription factors that act downstream of 
Notch to regulate neural precursor self-renewal (Kageyama 
et al., 2005). In situ hybridization revealed elevated levels of 
Hes1 transcript in cells of the VZ in p107−/− mice at E14.5 
(Fig. 2, a and b). Quantitative real-time RT-PCR further dem-
onstrated increased Hes1 mRNA in embryonic p107-defi cient 
cortices (Fig. 2 c). In contrast to Hes1 expression, no differ-
ence in Hes5 mRNA was detected by in situ hybridization or 
real-time RT-PCR (Fig. 2, d–f). An examination of Hes1 pro-
tein by Western blotting also revealed enhanced expression 
in neurospheres derived from p107−/− embryos (Fig. 2 g). 
 Although both Hes1 and Hes5 are Notch1 targets, only Hes1 is 
deregulated in p107−/− mice. The selective deregulation of 
Hes1 expression leads us to question whether p107 could regu-
late Hes1 transcription.
p107 represses Hes1 promoter activity
Because in situ hybridization and real-time RT-PCR reveal that 
Hes1 is deregulated in p107−/− neural precursors, we ques-
tioned whether p107 could regulate Hes1 transcription. To de-
termine whether the Hes1 promoter is responsive to p107, we 
used a luciferase promotor assay. The Hes1 promoter (1,500 bp) 
was inserted into a pGL3-Basic reporter vector containing the 
luciferase gene (B-Hes1; Fig. 3 a). This construct was trans-
fected into HEK 293A cells along with 3 μg of a p107 expres-
sion vector or Rb expression vector as a control. Cotransfection 
of 3 μg p107 resulted in a 2.5-fold reduction in Hes1 promoter 
activity (Fig. 3 b). This repression was dose dependent because 
a further increase in p107 (10 μg) resulted in a >10-fold 
 repression. In contrast, protein Rb (pRb) did not repress Hes1 
promoter activity. These results demonstrate that p107 represses 
Hes1 promotor activity.
Because p107 regulates transcription by interacting with E2F 
transcription factors, we asked whether E2Fs were required for 
p107-mediated repression. The Hes1 promotor was analyzed, and 
three putative E2F-binding sites (BSs [E2F-BS]) were found at po-
sitions −560, 161, and 398 bp relative to the transcription start site 
(Fig. 3 a). To test whether E2Fs were required for p107-mediated 
repression, we deleted all three BSs from the Hes1 promotor (Hes1-
3xBS). Cotransfection of the Hes1-3xBS construct with the p107 
expression vector resulted in pronounced repression of luciferase 
activity (Fig. 3 c). These results demonstrate that p107-mediated 
repression of the Hes1 promotor occurs indirectly, independent of 
these E2F sites. Nevertheless, our results showing decreased levels 
of Hes1 transcript and protein combined with p107- mediated 
repression of the Hes1 promoter demonstrate that p107 is required 
in the neural precursor population for the repression of Hes1.
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p107 regulates neural precursor numbers 
by the repression of Hes1
To ask whether p107 regulates the neural precursor popula-
tion by the repression of Hes1, we interbred p107-defi cient 
mice with animals carrying a null mutation for Hes1. We hy-
pothesized that if p107 regulated neural precursor cells by 
controlling the levels of Hes1, the loss of one or more alleles 
of Hes1 in p107-null mice should partially or completely re-
store the expanded precursor population to wild-type levels. 
Conversely, if p107 acted through an independent pathway, 
the number of neural precursors would not be affected by the 
loss of Hes1, as seen in wild-type cells. Because Hes1−/− 
mice are embryonic lethal after E12.5, embryos were taken at 
E10.5 (Ishibashi et al., 1995). The neuroepithelia from each 
embryo was dissociated into a single-cell suspension, cells 
were plated at clonal density, and, after 7 d, neurospheres 
were counted. Cultures from p107-null mice produced sub-
stantially more neurospheres than cultures from all other geno-
types (Fig. 4). Consistent with previous fi ndings (Ohtsuka et al., 
2001), the loss of Hes1 alone had no effect on neural pre-
cursor numbers from wild-type animals, whereas the absence 
of one or both alleles of Hes1 in p107- defi cient precursor 
cells restored neurosphere numbers to wild-type levels. Together 
with the demonstration that p107 represses Hes1 gene ex-
pression, these results demonstrate that the expanded neural 
precursor population in p107−/− embryos results from the de-
regulation of Hes1.
p107 regulates the neural precursor 
population in vivo through the repression 
of Hes1
We next questioned whether p107 controlled the size of the 
neural precursor population in vivo through the repression of 
Hes1. As a result of the embryonic lethality of double mutant 
mice, we asked whether the loss of a single Hes1 allele could 
restore the number of neural precursor cells in p107-null 
mice to wild-type levels. In adult mice, the precursor popula-
tion was labeled with BrdU. Counts of BrdU-positive cells in 
adult brains showed that a reduction in Hes1 could restore 
the number of proliferating precursors in p107-null mice 
(Fig. 5 a). PH3 immunohistochemistry of the rapidly divid-
ing E10.5 neural precursors demonstrated that loss of a sin-
gle Hes1 allele in p107-null embryos (Hes1+/−:p107−/−) 
reduced the number of cells in M phase to levels comparable 
with the wild type (Fig. 5 b). Similarly, a 2-h BrdU pulse in 
E13.5 embryos also revealed a reduction in the number of 
cells in S phase in p107−/− embryos lacking a single Hes1 
allele (Fig. 5 c). Loss of a single Hes1 allele in p107−/− mice 
restored the number of proliferating cells to wild-type levels 
at all three developmental time points. In contrast, loss of a 
single Hes1 allele on a wild-type background (Hes1+/−) did 
not result in a reduction in the number of proliferating cells 
(Fig. 5 c). These results demonstrate that p107 regulates the 
neural precursor population by controlling the levels of Hes1 
in progenitor cells.
Figure 4. Loss of Hes1 restores the number of neural precursors to wild-
type levels in p107−/− embryos. Quantifi cation of neurospheres revealed 
that p107−/− cultures produced signifi cantly more neurospheres than all of 
the other genotypes, including Hes1−/−:p107−/− and Hes1+/−:p107−/−. 
Therefore, a reduction in Hes1 expression in p107−/− mice restores the 
number of neural precursors back to wild-type levels (wild type, n = 3; 
p107−/−, n = 3; Hes1+/−:p107−/−, n = 6; Hes1−/−:p107−/−, n = 5; 
Hes1−/−, n = 3; Hes1+/−:p107+/−, n = 4; Hes1+/−:p107+/+, n = 4). 
Means were statistically analyzed by one-way analysis of variance fol-
lowed by Tukey’s individual comparison of the means. Error bars represent 
SEM. *, P < 0.05.
Figure 3. p107 represses Hes1 promoter activity. (a) Diagram of the 
Hes1 promotor (1,500 bp) containing three putative E2F-BSs at posi-
tions −560, 161, and 398 bp relative to the transcriptional start site. 
(b) Luciferase assay of HEK 293A cells transfected with the pGL3B-Luc 
Hes1 promoter constructs and 3 μg of expression vectors containing either 
Rb or p107. Rb has no effect on Hes1 promoter activity, whereas 3 μg 
p107 represses Hes1 promoter activity by a factor of 2.5, and 10 μg 
p107 represses 10-fold. (c) Transfection of the pGL3B-Luc Hes1-3xBS pro-
moter (E2F-binding mutant) with p107 still resulted in the repression of 
promoter activity, suggesting that p107 represses Hes1 transcription 
through an E2F-independent mechanism. Experiments were performed in 
triplicate. Means were statistically analyzed by one-way analysis of vari-
ance followed by Tukey’s individual comparison of the means. Error bars 
represent SEM. *, P < 0.05.
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Figure 5. p107 regulates the neural precursor population 
through the repression of Hes1. (a) Adult mice received intra-
peritoneal injections of BrdU to label proliferating cells over a 
10-h period. BrdU-positive cells were counted in every 10th 
section through the forebrains of wild-type (n = 3), Hes1+/−:
p107−/− (n = 4), and p107−/− (n = 5) mice. (b) Proliferating 
progenitors in E10.5 brains were identifi ed by PH3 immuno-
histochemistry. PH3-positive cells were counted in three repre-
sentative sections of wild-type (n = 3), Hes1+/−:p107−/− (n = 3), 
and p107−/− (n = 3) brains. (c) A 2-h BrdU pulse labeled 
proliferating progenitors in E13.5 brains. BrdU-positive cells 
were counted in four representative regions of the brain in 
wild-type (n = 4), Hes1+/−:p107−/− (n = 4), Hes1+/− (n = 4), 
and p107−/− (n = 3) embryos. Note that loss of a single 
Hes1 allele restored the numbers of progenitor cells to wild-
type levels in p107−/− mice at embryonic and adult ages. 
Means were statistically analyzed by one-way analysis of 
variance followed by Tukey’s individual comparison of the 
means. Error bars represent SEM. *, P < 0.05.
Figure 6. Reduced neuronal numbers in the developing cortex of p107−/− 
embryos. (a–c) To assess neuronal differentiation, coronal brain sections 
were stained for the neuronal marker NeuN. Immunohistochemistry on 
E18.5 brains revealed a reduction in the number of NeuN-positive cells in 
p107−/− cortices. (d–f) Brain measurements at E18.5 revealed signifi cantly 
thinner cortices and cortical mantle but no change in the size of the VZs in 
p107−/− embryos (wild type, n = 4; p107−/−, n = 4). Means for each 
measurement was assessed with a t test. Error bars represent SEM. *, P < 
0.05. Bar, 100 μm.
p107 defi ciency leads to a decreased 
number of mature neurons
The expanded neural precursor numbers in p107−/− mice lead 
us to question whether the number of cortical neurons was also 
affected. Specifi cally, we asked whether the expanded precursor 
population leads to increased neurogenesis. Immunohistochem-
istry with NeuN, a marker for mature central nervous system 
neurons, revealed a signifi cant reduction (P < 0.05) in the num-
ber of NeuN-expressing cells in p107−/− cortices (Fig. 6, a–c). 
The decreased number of cortical neurons is further demon-
strated by a reduction in the overall size/thickness of the cortex 
(Fig. 6, d and f), whereas measurements of the VZ did not reveal 
any differences between p107−/− mice and wild type at E18.5 
(Fig. 6 e). Because p107-defi cient mice exhibit a reduction in 
the total number of cortical neurons despite an expanded pro-
genitor pool, we questioned whether p107 was required for the 
survival of cortical neurons.
To determine whether an increase in cell death was re-
sponsible for the reduction in cortical neuron numbers in p107-
defi cient brains and at what stage in development cells were 
dying, we counted the number of apoptotic cells in the VZ/sub-VZ 
(SVZ), the intermediate zone (IZ), and in the cortical plate and 
marginal zone. Apoptotic cells were identifi ed by immunohisto-
chemistry for active caspase-3 and Hoechst nuclear staining 
in E13.5 embryonic brains (Fig. 7, a–f). The number of apop-
totic cells in the brains of wild-type and p107−/− mice was 
low, with less than one cell per 1,000-μm2 area (Fig. 7 h). As 
a result of the low frequency of apoptotic cells, counts were 
performed in 12 sections throughout the telencephalon in both 
left and right hemispheres, and the total number of apoptotic 
cells was compared between genotypes (Fig. 7 g). A twofold 
 increase in the number of apoptotic cells was observed only 
in the VZ/SVZ of p107-null brains, whereas no differences 
were observed in the IZ or cortical plate/marginal zone. An in-
crease in cell death in the p107 mutant VZ/SVZ suggests that 
newly committed neurons may be dying in the VZ before they 
initiate migration.
To identify at which stage in progenitor cell development 
cells were dying, double immunolabeling was performed with 
antibodies to active caspase-3 and Nestin (progenitor cell marker), 
doublecortin (migratory neuroblast), and βIII-tubulin (Tuj1, an 
early neuronal marker). Because the increase in apoptotic cells 
is only in the VZ/SVZ, we counted the double-labeled cells in 
this region. At E13.5, most cells were double labeled with active 
caspase-3/Nestin (Fig. 7, a–f), suggesting that p107 affects the 
survival of uncommitted progenitor cells. No double labeling 
was detected with doublecortin or Tuj1 in any of our samples, 
ruling out the possibility that p107 defi ciency results in en-
hanced cell death in newly committed neuroblasts. As apoptosis 
progresses, dying cells will lose their cell type–specifi c  markers; 
thus, some pyknotic cells did not colabel with Nestin or any 
other marker examined. The colabeling of apoptotic cells with 
caspase-3 and Nestin is consistent with the interpretation that 
cell death is occurring in uncommitted progenitor cells in the 
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VZ/SVZ. The increase in apoptosis in the VZ/SVZ did not reveal 
any death of newly committed neurons. In conclusion, these 
studies show that the absence of p107 results in the increased 
cell death of Nestin- expressing progenitor cells.
p107 controls neural progenitor 
commitment to a differentiated fate in vivo
As the increased apoptosis in the VZs of p107-null mice is caused 
by the death of uncommitted Nestin-expressing progenitor cells 
and the rate of cell death was still very low, we questioned 
whether the absence of p107 may result in a defect in the rate of 
neuronal commitment. To address this question, we performed 
neuronal birthdating assays using a BrdU protocol to label cells 
undergoing terminal mitosis at the time of BrdU  injection. 
Neuronal birthdating is based on the demonstration that neuro-
genesis occurs between E12 and 17, during which cohorts of 
neural precursors are born (neuronal commitment) at distinct time 
points and migrate out of the VZ to form the layers of the cortex 
(Caviness, 1982; Caviness et al., 1995; Takahashi et al., 1999). 
A single BrdU injection labels all cells in S phase, but only 
 neural precursors undergoing terminal mitosis retain the BrdU 
 label. Therefore, BrdU birthdating provides a quantitative anal-
ysis of cells that commit to a neuronal fate, undergo terminal 
mitosis, and migrate to their ultimate destination in the cerebral 
cortex. Accordingly, pregnant dams were injected with BrdU 
at E13.5 (Takahashi et al., 1999), the time at which deep layer 
cortical neurons are generated. Embryos were collected 5 d 
 after injection at E18.5. BrdU cell counts revealed that p107−/− 
mice (36 ± 5; n = 5) had a dramatic twofold reduction in the 
number of neurons that were born at injection time (E13.5) and 
reached the cortical plate by E18.5 relative to wild-type litter-
mates (68 ± 9; n = 4; Fig. 8, a–c). These results show that there 
is a decrease in the number of neurons reaching the cortical plate 
in p107-defi cient brains.
Because our examination of cell death did not reveal a 
loss of newly generated neurons in the cortical plate, we asked 
whether the reduced neuronal numbers in p107-defi cient mice 
was caused by fewer neurons born at E13.5 (the time of BrdU 
injection). To address this question, we performed a 24-h BrdU 
incorporation to measure the rate of neuronal commitment. 
Pregnant dams were injected at E13.5, embryos were collected 
24 h later at E14.5, and the number of strongly labeled BrdU-
positive cells were counted (i.e., cells that underwent terminal 
mitosis at the time of injection). In addition, sections were dou-
ble stained with PCNA to show that these cells are no longer 
cycling. Double labeling with BrdU and PCNA revealed that 
most BrdU-positive cells within the SVZ and IZ were no longer 
expressing PCNA, indicating that they were newly postmitotic 
(Fig. 8, d–f). Cell counts of this newly postmitotic population 
revealed a two-fold reduction in p107-defi cient brains compared 
with wild-type controls (Fig. 8, f and i). These results demon-
strate that there is a decrease in the number of newly postmitotic 
cells leaving the VZ in p107-defi cient animals.
We hypothesized that a decrease in the number of newly 
postmitotic cells migrating out of the VZ/SVZ in p107-defi cient 
mice indicates that p107 may be required for the regulation of 
neuronal commitment. To test this possibility, we performed the 
aforementioned 24-h BrdU commitment assay followed by dou-
ble labeling with BrdU and doublecortin to identify migrating 
neuroblasts or BrdU and Tuj1, an early panneuronal marker in-
duced just after terminal mitosis. Double labeling revealed that 
p107-defi cient mice exhibited a striking decrease in the number 
of BrdU-positive cells expressing doublecortin (wild type, 76.7 ± 
0.7; and p107−/−, 56.1 ± 4.1) and Tuj1 (wild type, 78.3 ± 3.2; 
and p107−/−, 49.5 ± 5.4; Fig. 8, j–o). These fi ndings support a 
model whereby fewer p107-defi cient progenitor cells commit to 
a neuronal fate, resulting in a twofold reduction in cortical neu-
rons in the brain at E18. In summary, our results reveal that p107 
is required for neuronal commitment and promotes the decision 
to exit the progenitor pool and commit to a neuronal fate.
Because our results show that Hes1 is involved in p107-
mediated neural precursor self-renewal and Hes1 functions to 
maintain the neural precursor population by repressing the ex-
pression of proneural genes (Sasai et al., 1992; Ishibashi et al., 
1995), we asked whether deregulated Hes1 could account for 
the defect in neurogenesis in p107-null mice. The loss of a 
Figure 7. Reduced neuronal numbers is not the result of enhanced apop-
tosis in the cortical plate. (a–f) To determine whether p107 was required for 
the survival of postmitotic neurons in the cortical plate, we counted the 
number of apoptotic cells in the developing cortex of E13.5 embryos. 
Apoptotic cells were identifi ed by active caspase-3 immunohistochemistry 
and Hoechst nuclear staining. (b and e) Within the SVZ/VZ, colabeling of 
active caspase-3 and Nestin identifi ed the majority of dying cells as un-
committed progenitors. (g) Total apoptotic cells were counted across 12 
representative sections in both left and right hemispheres through the telen-
cephalon. Cell counts revealed an increase in apoptosis in the VZ/SVZ of 
p107−/− embryos but not in the developing cortex (wild type, n = 4; 
p107−/−, n = 4). (h) The number of apoptotic cells per 1,000-μm length 
along the ventricle and up through to the pial layer showed an extremely 
low frequency of cell death per counting area. Mean counts were assessed 
by a two-way analysis of variance followed by Bonferroni’s individual com-
parison of means. CP, cortical plate; MZ, marginal zone. Error bars repre-
sent SEM. *, P < 0.05. Bar, 25 μm.
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single Hes1 allele could partially restore the rate of neurogene-
sis by increasing the number of neurons that commit to a neuro-
nal fate at E13.5. Specifi cally, BrdU birthdating revealed that a 
reduction in Hes1 could restore the number of neurons born at 
E13.5 from 37 ± 5 (n = 4) in p107−/− to 59 ± 3 (n = 6) in 
Hes1+/−:p107−/− comparable with wild-type levels of 68 ± 9 
(n = 4; Fig. 9). These results highlight that p107 regulates the 
neural precursor pool by regulating self-renewal and controlling 
the decision to exit the progenitor pool and commit to a neuronal 
fate. Furthermore, we show that the mechanisms underlying 
p107-mediated regulation of the neural precursor population is 
through repression of the Notch–Hes1 pathway.
Discussion
In this study, we identify a novel role for p107 in regulating the 
transition from proliferating neural progenitor cell to committed 
neuroblast. During neural development, p107 regulates the size 
of the neural precursor pool by limiting self-renewal capacity 
and promoting the transition from progenitor cell to committed 
neuroblast. Furthermore, we show that the mechanism by which 
p107 regulates the neural precursor pool is through repression 
of Notch–Hes1 signaling.
The cell cycle protein p107 regulates 
neural precursor self-renewal through 
the repression of Hes1
In this study, we demonstrate that p107 regulates neural pre-
cursor self-renewal through the repression of Hes1. Our previous 
work has shown that p107-defi cient neural precursors have an 
enhanced self-renewal capacity and that Notch1 and Hes1 are 
up-regulated (Vanderluit et al., 2004). Because we observed an 
up-regulation of only Hes1 and not Hes5, we questioned whether 
p107 might be acting at multiple levels along the Notch–Hes1 
pathway. Although promotor analysis reveals that Hes1 repression 
is indirect, likely resulting from Notch activation, these experi-
ments set the rationale for using the Hes1 mutant mice to reduce 
signaling through the Notch1 pathway. By interbreeding p107 
and Hes1 mutant mice, the defect found in p107 mutant is rescued. 
Figure 8. Defective differentiation in p107−/− neural precursors. Long-
term BrdU birthdating analysis (E13–18) showed a reduction in the num-
ber of cells exiting the VZ and arriving in the cortical plate. Pregnant 
females received an intraperitoneal injection of 20 mg/kg BrdU at gesta-
tion day 13.5 (E13.5). Embryos were collected 5 d later at E18.5, and 
BrdU+ cells were counted in the developing cortices. (a–c) p107−/− em-
bryos had signifi cantly fewer BrdU+ cells in the cortex in contrast to wild-
type embryos (wild type, n = 4; p107−/−, n = 4). (d–f) To assess the 
number of neurons born at E13, short-term BrdU birthdating (E13–14) was 
performed with pregnant females receiving an intraperitoneal injection of 
20 mg/kg BrdU at E13.5, and embryos were collected 24 h later at 
E14.5. (d and e) Strongly labeled BrdU+ cells were primarily located in the 
IZ and SVZ. (f) Quantifi cation of the number of strongly labeled BrdU+ cells 
revealed a signifi cant reduction in p107-defi cient brains. (g–i) Double 
 labeling of BrdU and PCNA was performed to assess whether cells had 
undergone terminal mitosis and exited the cell cycle (i.e., BrdU+ PCNA− 
cells; arrows). (j–o) Strongly labeled BrdU+ cells were colabeled with dou-
blecortin (DCX), a marker of migratory cells (j–l), and Tuj1, an early neuro-
nal marker identifying these cells as newly born neurons (m–o). Arrows in 
j, k, m, and n identify double-labeled cells. The lower number of BrdU-positive 
cells in the cortex of p107−/− embryos at E18.5 and in the SVZ and IZ at 
E14.5 despite an expanded precursor population demonstrates a defect in 
the commitment to a neuronal fate. Means for each measurement was as-
sessed with a t test. Error bars represent SEM. cp, cortical plate. *, P < 0.05. 
Bars: (a–e) 100 μm; (g, h, j, k, m, and n) 25 μm.
Figure 9. A reduction in Hes1 restores cortical neurogenesis in p107-
 defi cient brains. Long-term BrdU birthdating (E13–18) of wild-type (n = 4), 
Hes1+/−:p107−/− (n = 6), and p107−/− (n = 4) embryos revealed that 
loss of a single Hes1 allele could restore neurogenesis in p107-defi cient 
brains. Means were statistically analyzed by one-way analysis of variance 
followed by Tukey’s individual comparison of the means. Error bars repre-
sent SEM. *, P < 0.05; **, P < 0.01.
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The loss of one or more Hes1 alleles in p107-defi cient mice re-
stores both the size of the neural precursor pool to wild-type 
levels and the differentiation defect. These results identify a 
novel mechanism whereby p107, a cell cycle protein, regulates 
the neural precursor population through the repression of Hes1, 
a gene that inhibits differentiation by repressing proneural gene 
transcription. Although previous studies have shown that cell 
cycle inhibitors such as the CDKIs (p16Ink4a, p18Ink4c, p19Arf, 
p21Cip1, and p27Kip1) negatively regulate neural precursor pro-
liferation, they function by direct inhibition of the cell cycle 
 machinery  (cyclin kinases; Cheng et al., 2000; Doetsch et al., 
2002; Molofsky et al., 2003, 2005; Yuan et al., 2004; Kippin 
et al., 2005). In contrast, p107 regulates the transcription not only 
of cell cycle genes but also genes that impact the onset of differ-
entiation, such as Hes1. Our studies support a novel concept 
whereby the role of cell cycle genes such as p107 extends beyond 
regulation of the cell cycle machinery and directly impacts the 
onset of differentiation in the developing nervous system.
p107 promotes progenitor commitment 
to a neuronal fate
During cortical development, progenitor cells in the VZ commit 
to a neuronal fate, undergo terminal mitosis, and commence migra-
tion into the cortical plate, where they undergo differentiation. 
Previously, we demonstrated that p107 regulates neural pre-
cursor numbers by limiting self-renewal (Vanderluit et al., 
2004). In the present study, we extend these fi ndings to show 
that p107 has an additional function in controlling this popula-
tion by regulating commitment to a neuronal fate. p107- defi cient 
mice have an overall reduction in the number of cortical  neurons, 
resulting in considerably smaller brains despite an expansion of 
the neural precursor population. This was not caused by the in-
creased cell death of committed neurons because no difference 
in the number of apoptotic cells in the p107-defi cient cortical 
plate was found. Although an increase in apoptosis was  observed 
in the VZ/SVZ of p107-defi cient mice, double labeling revealed 
that these cells coexpressed Nestin, indicating that apoptosis 
was elevated in uncommitted progenitor cells. Consistent with 
this, there was no double labeling of VZ/SVZ apoptotic cells with 
doublecortin or Tuj1, which are markers for newly committed 
neurons. There is the possibility that newly committed SVZ 
progenitors may undergo apoptosis before the expression of 
early commitment markers, but the frequency of apoptotic cells 
is very low, making this interpretation unlikely.
In further support of a defect in neuronal commitment, 
we performed a 24-h (E13–14) BrdU labeling analysis, which 
revealed a substantial reduction in the number of newly com-
mitted neurons in p107-defi cient brains (Fig. 8). These fi ndings 
support our long-term birthdating (E13–18) study that demon-
strated a twofold decrease in the number of cortical neurons 
(Fig. 6), further supporting a model whereby fewer neurons are 
born during the time that neurogenesis takes place in the devel-
oping p107-defi cient cortex. This demonstrates that p107 pro-
motes progenitor cell commitment to a neuronal fate. Whereas 
in p107-defi cient mice, expanded precursor populations have 
been identifi ed in neuronal, myeloid, and adipocyte lineages 
(LeCouter et al., 1998; Vanderluit et al., 2004; Scime et al., 2005), 
our studies reveal a striking defect in the ability of progenitor 
cells to commit to a neuronal fate and undergo differentiation. 
Furthermore, the mechanism underlying this defect is through 
the deregulation of Hes1, an inhibitor of differentiation that fun-
ctions by repressing the proneurogenic genes Ngn1, Mash1, and 
NeuroD (Sasai et al.,  1992; Ishibashi et al., 1995). Collectively, 
these results reveal a novel function for p107 in promoting neu-
ral precursor cell commitment to a neuronal fate.
Rb family members perform distinct roles 
in neurogenesis
Collectively with our previous fi ndings (Ferguson et al., 2002; 
Vanderluit et al., 2004), the results of this study reveal tempo-
rally sequential functions for Rb family proteins during the 
course of neural development (Fig. 10). First, p107 is expressed 
in proliferating neural precursor cells and controls the size of the 
neural precursor population. It does so by regulating neural pre-
cursor self-renewal and commitment to a neuronal fate. In the 
absence of p107, the progenitor pool is expanded by increased 
self-renewal and impairment in neuronal commitment. This 
function is unique for p107 because pRb-null mice do not ex-
hibit an expanded population of neural precursor cells, nor do 
they show a decrease in neurogenesis (Ferguson et al., 2002). 
The temporal requirement for pRb occurs at the time of neuronal 
differentiation. Unlike p107-defi cient animals, pRb-null progen-
itors successfully commit to a neuronal fate but exhibit impair-
ment in migration and differentiation. This is evident by the 
widespread ectopic mitoses of committed progenitors through-
out the developing cortex. Furthermore, committed neuroblasts 
derived from the ventral populations fail to migrate through their 
tangential trajectories to reach their fi nal destinations in the dor-
sal telencephalon (Ferguson et al., 2002, 2005). Thus, as p107 
becomes down-regulated, pRb plays an essential role to regulate 
differentiation and neuronal migration. Once neurons complete 
terminal differentiation, pRb becomes down-regulated, and p130 
becomes the predominant Rb family member (Jiang et al., 1997; 
Figure 10. Rb family members have distinct roles in neurogenesis. In the 
progression from stem cell to differentiated neuron, Rb family members func-
tion sequentially to regulate each stage. In the neural precursor compart-
ment, p107 performs two distinct functions. Within the neural stem cell 
population, p107 negatively regulates self-renewal, which ultimately affects 
the overall size of the neural precursor population. In the mature neural pro-
genitor, p107 functions to promote commitment to a differentiated state. 
After neuronal commitment, Rb takes over to regulate terminal mitosis and 
migration of newly differentiated neurons. As cells become postmitotic, p130 
functions to regulate cell survival (Liu and Greene, 2001; Liu et al., 2005).
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Gill et al., 1998; Callaghan et al., 1999; Ferguson et al., 2000; 
Yoshikawa, 2000). Recent studies reveal that p130 is highly ex-
pressed in postmitotic cells and plays an important role in the 
regulation of neuronal survival (Liu and Greene, 2001; Liu et al., 
2005). Thus, each Rb family protein plays a temporally distinct 
role that is crucial for normal neural development.
In conclusion, the key fi nding of this study is that p107, a 
cell cycle regulatory protein known for its role in controlling the 
cell cycle machinery, has a novel function in regulating the on-
set of differentiation. This new role provides insight as to how 
cell cycle proteins may participate in shaping the developing 
brain. We also show that deregulation of the Notch1 pathway is 
mechanistically important because deletion of a single allele of 
Hes1 rescues the defects found in p107-defi cient mice but has 
no effect on wild-type animals. In summary, we have identifi ed 
a novel function for the cell cycle regulator p107 in promoting 
progenitor cell differentiation through regulation of the Notch–
Hes1 signaling pathway.
Materials and methods
Mice
Germline p107-null mice were generated previously by LeCouter et al. 
(1998) and maintained on a mixed SV-129 and C57BL/6 background. 
Germline Hes1-null mice on an ICR background were originally generated 
by R. Kageyama (Ishibashi et al., 1995). Hes1/p107-defi cient embryos 
were generated by interbreeding heterozygous (Hes1+/−) mice with 
p107+/− mice. Animals were genotyped according to standard protocols 
with previously published primers for p107 (LeCouter et al., 1998) and 
Hes1 (Ishibashi et al., 1995). For embryonic time points, the time of plug 
identifi cation was counted as E0.5. All experiments were approved by the 
University of Ottawa’s Animal Care Ethics Committee, adhering to the 
guidelines of the Canadian Council on Animal Care.
Tissue fi xation and cryoprotection
Pregnant dams and adult mice were killed with a lethal injection of sodium 
pentobarbitol. Embryos were dissected and submersion fi xed overnight in 
4% PFA in 1× PBS, pH 7.4. Adult mice were perfused with 1× PBS fol-
lowed by cold 4% PFA, and brains were removed. Brains were postfi xed 
overnight in 4% PFA, cryoprotected in 22% sucrose in 1× PBS, and frozen, 
and 14-μm coronal sections through the forebrain were collected on Super-
frost Plus slides (Fisher Scientifi c).
In situ hybridization and quantitative real-time RT-PCR
Nonradioactive in situ hybridization and digoxigenin probe labeling was 
performed according to previously described protocols (Wallace and Raff, 
1999). Antisense riboprobes for Hes1 and Hes5 were generated according 
to previously published sequences (Tomita et al., 1996). Total RNA was iso-
lated from cortices from wild-type and p107-defi cient embryos using TRIzol 
reagent according to the manufacturer’s instructions (Invitrogen). RNA was 
reverse transcribed using the GeneAmp RNA PCR Core kit (Applied Bio-
systems). Real-time PCR was performed on cDNA using the TaqMan Universal 
PCR Master Mix (Applied Biosystems) with commercially provided PCR 
primers for Hes1, Hes5, and glyceraldehyde-3-phoshpate dehydrogenase 
from TaqMan Gene Expression Assays (Applied Biosystems).
Immunohistochemistry and Western blotting
Immunohistochemistry was performed on coronal cryostat sections from 
 embryonic and adult brains with primary antibodies to mouse anti-NeuN 
(1:100; Chemicon), rabbit antiactive caspase-3 (1:500; BD Biosciences), 
rabbit anti-PH3 (1:400; Upstate Biotechnology), rat anti-BrdU (1:100; 
 Accurate Chemicals), mouse anti-BrdU (1:100; Becton Dickinson), mouse 
anti-PCNA (1:300; Vector Laboratories), goat antidoublecortin (1:100; 
Santa Cruz Biotechnology, Inc.), mouse anti–βIII-tubulin (mouse monoclonal 
hybridoma supernatant; 1:100; Caccamo et al., 1989), and mouse anti-
Nestin (1:400; Research Diagnostics). For BrdU birthdating experiments 
(E13.5–18.5), pregnant dams received a single injection of BrdU at 
20 μg/g of body weight; for short-term BrdU incorporation experiments, 
pregnant dams and adult mice received intraperitoneal injections of BrdU 
at 100 μg/g of body weight. For BrdU detection, sections were denatured 
in 2 N HCl at 37°C for 15 min followed by neutralization in 0.1 M Na 
 borate, pH 8.5, for 10 min at room temperature before incubation with the 
primary antibody. For PCNA detection, sodium citrate antigen retrieval, 
pH 6.0, was performed on sections before incubation with PCNA antibodies. 
In all double labeling with BrdU antibodies, denaturation and BrdU immuno-
histochemistry were performed after the fi rst primary and secondary anti-
body incubation.
Protein was isolated from cultured neurospheres in lysis buffer, run 
on a 15% SDS-polyacrylamide gel, and transferred to a nitrocellulose 
membrane as described previously (Ferguson et al., 2000). Immunoblot-
ting was performed with antibodies directed against Hes1 (provided by 
H. Kitamura, Yokohama City University School of Medicine, Yokohama, 
Japan; Ito et al., 2000), Hes5 (Chemicon), and actin (Santa Cruz Biotech-
nology, Inc.). Blots were developed by chemiluminescence according to the 
manufacturer’s instructions (NEL100; PerkinElmer).
Cell counts and measurements
In the adult brain, BrdU+ cells were counted along the entire length of the 
ventricular surface (dorsal and ventral) in every 10th section from the rostral 
crossing of the corpus callosum to the start of the third ventricle and crossing 
of the anterior commissure with an equal number of sections counted per 
brain as previously described (Morshead et al., 1998; Vanderluit et al., 
2004). PH3+ cells were counted along a 1,000-μm length of the ventricle 
in three representative sections through the forebrains of E10.5 embryos. 
In E13.5, 14.5, and 18.5 embryos, BrdU+ cells and/or NeuN+ cells were 
counted along a 750-μm length of the ventricle up through to the pial sur-
face in four representative regions through the forebrain (Koutmani et al., 
2004). Cortical plate, VZ, and cortical mantle measurements were per-
formed on cresyl violet sections of E18 brains from wild type. Triplicate 
measurements were performed on three representative sections through 
the forebrain.
Promotor analysis
The Hes1 promotor (1,270 bp) sequence, including a 224-bp 3′ sequence 
of the transcription start site, was amplifi ed from mouse genomic DNA by 
PCR and inserted into a pGL3-Basic luciferase reporter construct (forward 
primer 5′-C G C G G C G G C A A T A A A A C A T C -3′; reverse primer 5′-G A T G A G-
T G C A C A G G G G G A G A A A A G A G G T C -3′; Promega; Sasai et al., 1992; 
Takebayashi et al., 1994). To assess whether promotor activity was affected 
by p107, the pGL3B-Hes1 construct or the E2F-BS mutant (Hes1-3xBS) was 
cotransfected with expression vectors for either p107 (pCMV-p107) or Rb 
(pGK-RB) into HEK 293A cells by standard calcium phosphate precipitation 
(Storring et al., 1999). 2 μg pMLV-LacZ was cotransfected with each sam-
ple to control for transfection effi ciency. 4-methylumbelliferyl-D-galactoside 
assay was performed to standardize the transfection reaction, and lucifer-
ase activity was assessed according to standard procedures (Fortin et al., 
2004). Statistical analysis was performed on the means of three dif-
ferent experiments.
Table I. Primers for E2F-mutated Hes1 promotor construct
Forward Reverse
Fragment 1 5′-A T C G G G T A C C C G C G G G G C A A T A A A A C A T C -3′ 5′-T A G C A G A T C T C C C T T A C C G T C C C -3′
Fragment 2 5′-A T C G A G A T C T G G G T T T A G T A T C T C C -3′ 5′-T A G C C T C G A G G C T T A C G T C C T T T T A C T T G -3′
Fragment 3 5′-A T C G C T C G A G G G A T T C C A A A A A T A A A A T T C -3 5′-T A G C G C T A G C A A A G G A G T C C C G C T G -3′
Fragment 4 5′-A T C G G C T A G C A C C T C G G G G T G A A A T G G -3′ 5′-T A G C A A G C T T C A C G T A C G G A A T G C C A G C -3′
Primers were designed to exclude each of the three putative E2F-BSs, resulting in fragmentation of the Hes1 promotor into four pieces. Restriction sites were incorpo-
rated into primer ends to ease promotor reassembly.
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Putative E2F consensus sites were identifi ed by MatInspector software 
(Genomatix; Fig. 3 a). A mutant Hes1 promotor minus all three E2F-binding 
sequences (Hes1-3xBS) was constructed by linking PCR fragments on 
each side of the E2F-BSs and inserting them into the pGL3B-luciferase con-
struct (Table I).
Neurosphere assay
The neurosphere assay was performed on neuroepithelia from E10.5 em-
bryos as previously described (Reynolds et al., 1992; Tropepe et al., 
1999; Vanderluit et al., 2004). Statistical comparisons were performed on 
the mean number of neurospheres per embryo per genotype.
Microscopy
Sections treated for immunohistochemistry or in situ hybridization were ex-
amined by a microscope (Axioskop 2; Carl Zeiss MicroImaging, Inc.) with 
standard fl uorescence and brightfi eld/darkfi eld settings at 5× NA 0.25 or 
20× NA 0.50 objectives. Images were captured using a color video camera 
(Power HAD 3CCD; Sony) with Northern Eclipse software (Empix Imaging). 
For confocal microscopy, images were captured using a microscope (LSM 
510 META; Carl Zeiss MicroImaging, Inc.) on an inverted microscope 
(Axiovert 200M; Carl Zeiss MicroImaging, Inc.) with the manufacturer’s 
integrated digital imaging software. Figures were compiled using Photo-
shop 6.0 (Adobe). Manipulations of brightness and intensity were made 
equally to all treatment groups.
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